1Y Close · As of Aug 26, 2026
HYUNDAI PHARMACEUTICAL operates in the Pharmaceuticals sector.
Legal name: HYUNDAI PHARMACEUTICAL CO., LTD
As of the Aug 26, 2026 close, the market capitalization was 194.2 billion KRW, with a P/B of 2.37.
These figures can be verified in the DART filing (receipt no. 20260213002543).
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 2 disposal(s).
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.